Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study

R S Khattar1, R Senior, A Lahiri

  • 1Department of Cardiovascular Medicine, Northwick Park, and St Mark's Hospital NHS Trust and Institute for Medical Research, Harrow, Middlesex, UK.

Circulation
|November 3, 1998
PubMed

Insights

White-coat hypertension poses a lower cardiovascular disease risk than sustained mild hypertension. This study found white-coat hypertensives experienced fewer events and less organ damage.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Preventive Medicine

Background:

  • Hypertension is a major risk factor for cardiovascular disease (CVD).
  • Differentiating between white-coat hypertension and sustained hypertension is crucial for risk assessment.
  • Previous studies have yielded conflicting results on the long-term prognosis of white-coat hypertension.

Purpose of the Study:

  • To compare the cardiovascular disease risk associated with white-coat hypertension versus sustained mild hypertension.
  • To identify predictors of cardiovascular events in patients with elevated clinic blood pressure.

Main Methods:

  • 479 patients with elevated clinic systolic blood pressure (140-180 mm Hg) underwent 24-hour ambulatory blood pressure monitoring.
  • Patients were followed for a mean of 9.1 years for cardiovascular events.
  • Subgroup analysis included echocardiography and carotid ultrasound to assess organ damage.

Main Results:

  • White-coat hypertension (elevated clinic BP, normal ambulatory BP) was diagnosed in 126 patients.
  • White-coat hypertensives were younger and had a significantly lower incidence of CVD events (1.32 vs. 2.56 events per 100 patient-years) compared to sustained hypertensives.
  • White-coat hypertension was an independent predictor of fewer cardiovascular events (HR, 0.29; P=0.04), with less left ventricular and carotid hypertrophy observed.

Conclusions:

  • White-coat hypertension is associated with a relatively benign prognosis compared to sustained mild hypertension.
  • These findings support a less aggressive management approach for white-coat hypertension.
  • Further research may clarify the optimal monitoring and treatment strategies for different hypertensive phenotypes.
Abstract

Related Concept Videos

Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...